Literature DB >> 15266408

Wnt/Frizzled signaling in Ewing sarcoma.

Aykut Uren1, Vladimir Wolf, Yu-Feng Sun, Amir Azari, Jeffrey S Rubin, Jeffrey A Toretsky.   

Abstract

BACKGROUND: The Ewing sarcoma family of tumors (ESFT) is a set of neuroectodermal malignancies that typically presents in the second decade and has a poor prognosis due to metastatic disease. Wnt signaling has a critical role in the normal development of multiple neuroectodermal tissues and also contributes to the neoplastic properties of tumor cells of neuroectodermal origin. PROCEDURE: We surveyed the expression of Wnts and their receptors in nine ESFT cell lines by RT-PCR analysis. We also tested biological response of ESFT cell lines to exogenous Wnts in beta-catenin stabilization, actin stress fiber formation, and chemotaxis assays.
RESULTS: We detected Wnt-10b in all the lines, and most also expressed Wnt-5a, Wnt-11, and Wnt-13. Several Frizzleds (Fz) and the Wnt co-receptors, low density lipoprotein-receptor-like proteins 5 and 6 were also expressed. We observed a marked stimulation of the beta-catenin/canonical Wnt pathway in ESFT cells treated with Wnt-3a. Wnt-3a induced morphologic changes characterized by the formation of long cytoplasmic extensions in ESFT cells. We also observed chemotaxis of ESFT cells in response to Wnt-3a.
CONCLUSIONS: These results provide evidence that components of Wnt/Fz pathway are expressed and an intact Wnt/Frizzled signaling pathway exists in ESFT cell lines. Activation of the Wnt pathway in ESFT suggests that Wnt modulates cell motility rather than cell proliferation. Hence, activation of this pathway may influence metastatic potential of ESFT. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15266408     DOI: 10.1002/pbc.20124

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  21 in total

1.  Role of Wnt signaling in bone remodeling and repair.

Authors:  Paul S Issack; David L Helfet; Joseph M Lane
Journal:  HSS J       Date:  2007-12-08

Review 2.  Wnt/β-catenin pathway in bone cancers.

Authors:  Jian Tian; Hongbo He; Guanghua Lei
Journal:  Tumour Biol       Date:  2014-08-13

3.  Wnt/β-catenin-activated Ewing sarcoma cells promote the angiogenic switch.

Authors:  Allegra G Hawkins; Elisabeth A Pedersen; Sydney Treichel; Kelsey Temprine; Colin Sperring; Jay A Read; Brian Magnuson; Rashmi Chugh; Elizabeth R Lawlor
Journal:  JCI Insight       Date:  2020-07-09

4.  Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.

Authors:  Jenny Potratz; Amelie Tillmanns; Philipp Berning; Eberhard Korsching; Christiane Schaefer; Birgit Lechtape; Carolin Schleithoff; Rebekka Unland; Karl-Ludwig Schäfer; Carsten Müller-Tidow; Heribert Jürgens; Uta Dirksen
Journal:  Mol Oncol       Date:  2015-12-20       Impact factor: 6.603

5.  BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression.

Authors:  Dorothea Douglas; Jessie Hao-Ru Hsu; Long Hung; Aaron Cooper; Diana Abdueva; John van Doorninck; Grace Peng; Hiro Shimada; Timothy J Triche; Elizabeth R Lawlor
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

Review 6.  Ewing's sarcoma: standard and experimental treatment options.

Authors:  Vivek Subbiah; Pete Anderson; Alexander J Lazar; Emily Burdett; Kevin Raymond; Joseph A Ludwig
Journal:  Curr Treat Options Oncol       Date:  2009-06-17

7.  Critical signaling pathways in bone sarcoma: candidates for therapeutic interventions.

Authors:  Mandy Geryk-Hall; Dennis P M Hughes
Journal:  Curr Oncol Rep       Date:  2009-11       Impact factor: 5.075

8.  Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism.

Authors:  Yoshimi Endo; Elspeth Beauchamp; David Woods; William G Taylor; Jeffrey A Toretsky; Aykut Uren; Jeffrey S Rubin
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

9.  Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors.

Authors:  Miwa Tanaka; Yukari Yamazaki; Yohei Kanno; Katsuhide Igarashi; Ken-ichi Aisaki; Jun Kanno; Takuro Nakamura
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

10.  LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin Signaling.

Authors:  Christopher A Scannell; Elisabeth A Pedersen; Jack T Mosher; Melanie Anne Krook; Lauren A Nicholls; Breelyn A Wilky; David M Loeb; Elizabeth R Lawlor
Journal:  Front Oncol       Date:  2013-04-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.